Abstract

We describe development of an absolute multiplex quantitative real-time PCR for detection of Plasmodium spp., P. falciparum and P. vivax targets in order to produce an assay amenable to high throughput but with reduced costs. Important qPCR experimental details and information that is critical to performance and reliability of assay results were investigated. Inhibition studies were performed to test and compare co-purification of PCR inhibitors in samples extracted from whole blood using either the manual or automated methods. To establish the most optimal qPCR reaction volume, volume titration of the reaction master mix was performed starting at 10 µl to 1 µl reaction master mix with 1 µl of template DNA in each reaction. As the reaction volume decreased, qPCR assays became more efficient with 1 µl reaction master mix being the most efficient. For more accurate quantification of parasites in a sample, we developed plasmid DNAs for all the three assay targets for absolute quantification. All of absolute qPCR assays performed with efficiency of more than 94%, R2 values greater than 0.99 and the STDEV of each replicate was <0.167. Linear regression plots generated from absolute qPCR assays were used to estimate the corresponding parasite density from relative qPCR in terms of parasite/µl. One copy of plasmid DNA was established to be equivalent to 0.1 parasite/µl for Plasmodium spp. assay, 0.281 parasites for P. falciparum assay and 0.127 parasite/µl for P. vivax assay. This study demonstrates for the first time use of plasmid DNA in absolute quantification of malaria parasite. The use of plasmid DNA standard in quantification of malaria parasite will be critical as efforts are underway to harmonize molecular assays used in diagnosis of malaria.

Highlights

  • Malaria remains one of the most burdensome and lethal infectious diseases in tropical and sub-tropical countries

  • Design and Analysis of Multiplex Quantitative Real-time PCR (qPCR) A multiplex qPCR assay was designed to simultaneously detect Plasmodium spp., P. falciparum, P. vivax and human RNaseP gene as an endogenous control. These assays are referred to as follows in the manuscript: the Plasmodium spp. assay is referred to as PLU assay, the P. falciparum assay as FAL assay, and the P. vivax as VIV assay

  • The performance of each primer and probe set as a singleplex assay and multiplex assay was assessed

Read more

Summary

Introduction

Malaria remains one of the most burdensome and lethal infectious diseases in tropical and sub-tropical countries. Despite gains made in diagnosis of malaria by use of molecular methods, microscopy remains the gold standard technique for diagnosing and quantifying malaria. Microscopy has many limitations such as the need for the extensive training, inter-observer variability, difficulty in certifying results, and low sensitivity [1,2]. Quantitative Real-time PCR (qPCR) is commonly used as a confirmatory method for malaria diagnosis especially in clinical trials and in reference laboratories where precise quantification is critical [3,4,5]. PCR offers several advantages over microscopy in diagnosis of malaria in several regards. PCR can be used for precise parasite quantification through qPCR methods. Relative quantification is used in qPCR where the parasite density is first determined by microscopy. Diluted DNA from the sample with known parasite density is used as a standard to determine parasite density of the unknown [3,4,5,6,7,8,11]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call